Skip to main content
. 2021 Oct 8;8:738281. doi: 10.3389/fnut.2021.738281

Figure 6.

Figure 6

Effect of DON and BZN in mRNA levels of hormone genes in hypothalamus (A) and pituitary gland (B). Column was mean ± SEM (n = 7). Different letters mean significant differences. Dietary treatment: Con, basal diet; DON, 4 mg/kg DON-contaminated diet; BZN, 0.5% BZN supplementation diet; DBZN, 0.5% BZN supplement in 4 mg/kg DON-contaminated diet. SST, somatostatin; INR, insulin receptor; CCK-2R, cholecystokinin B receptor; NPY, neuropeptide Y; AKT, AKT serine/threonine kinase 1; HTR3A1, 5-hydroxytryptamine receptor 3A 1; HTR3A2, 5-hydroxytryptamine receptor 3A 2; HTR3B2, 5-hydroxytryptamine receptor 3B; COX-2, cyclooxygenase-2; CCK-1R, cholecystokinin type A receptor; GLP-2, glucagon-like peptide 2; BZN, baicalin–zinc complex; Con, control; DON, deoxynivalenol. a,bdifferent letters means significantly difference (P < 0.05).